BR9602758A - Composição farmacêutica oral organoleticamente aceitável - Google Patents

Composição farmacêutica oral organoleticamente aceitável

Info

Publication number
BR9602758A
BR9602758A BR9602758A BR9602758A BR9602758A BR 9602758 A BR9602758 A BR 9602758A BR 9602758 A BR9602758 A BR 9602758A BR 9602758 A BR9602758 A BR 9602758A BR 9602758 A BR9602758 A BR 9602758A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
oral pharmaceutical
acceptable oral
organoleptically acceptable
organoleptically
Prior art date
Application number
BR9602758A
Other languages
English (en)
Inventor
Leslie George Humber
Gerald Louis Reuter
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR9602758A publication Critical patent/BR9602758A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
BR9602758A 1995-06-13 1996-06-12 Composição farmacêutica oral organoleticamente aceitável BR9602758A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17195P 1995-06-13 1995-06-13

Publications (1)

Publication Number Publication Date
BR9602758A true BR9602758A (pt) 1998-04-22

Family

ID=21690247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9602758A BR9602758A (pt) 1995-06-13 1996-06-12 Composição farmacêutica oral organoleticamente aceitável

Country Status (26)

Country Link
US (1) US5958445A (pt)
EP (1) EP0748628A3 (pt)
JP (1) JPH093071A (pt)
KR (1) KR970000228A (pt)
CN (1) CN1152434A (pt)
AR (1) AR003435A1 (pt)
AU (1) AU711853B2 (pt)
BR (1) BR9602758A (pt)
CA (1) CA2178686A1 (pt)
CO (1) CO4700456A1 (pt)
CZ (1) CZ170296A3 (pt)
EA (1) EA000047B1 (pt)
EE (1) EE9600067A (pt)
HU (1) HUP9601635A3 (pt)
IL (1) IL118636A (pt)
IN (1) IN182040B (pt)
MA (1) MA23907A1 (pt)
NO (1) NO962491L (pt)
NZ (1) NZ286791A (pt)
PE (1) PE10898A1 (pt)
PL (1) PL314732A1 (pt)
SG (1) SG46737A1 (pt)
SK (1) SK74396A3 (pt)
SV (1) SV1996000051A (pt)
TR (1) TR199600499A2 (pt)
ZA (1) ZA964928B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0974366T3 (da) 1997-03-28 2007-01-29 Eisai Co Ltd Orale, farmaceutiske præparater med nedsat bitterhed ved maskering
WO2001019349A2 (en) * 1999-09-10 2001-03-22 Ranbaxy Laboratories Limited Extended release formulation of etodolac
AU7595300A (en) * 1999-09-22 2001-04-24 Akzo Nobel N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
KR100416242B1 (ko) * 1999-12-22 2004-01-31 주식회사 삼양사 약물전달체용 생분해성 블록 공중합체의 액체 조성물 및이의 제조방법
US7727548B2 (en) 2000-03-01 2010-06-01 Eisai R&D Management Co., Ltd. Rapidly disintegrable tablet containing polyvinyl alcohol
US6514537B1 (en) 2000-06-02 2003-02-04 Cumberland Swan Holdings, Inc. Magnesium citrate solution
MXPA03001407A (es) * 2000-08-18 2003-06-06 Pharmacia Corp Formulacion oral de desintegracion rapida de un inhibidor de ciclooxigenasa-2.
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
WO2002067894A2 (en) * 2001-02-27 2002-09-06 Ranbaxy Laboratories Limited Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
JP2005506987A (ja) * 2001-09-26 2005-03-10 ファルマシア・コーポレーション 感覚的に許容される口内崩壊性組成物
WO2003055525A1 (fr) * 2001-12-25 2003-07-10 Takeda Chemical Industries, Ltd. Preparations contenant un acide
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
WO2005072775A1 (ja) * 2004-01-29 2005-08-11 Medrx Co., Ltd. 消炎鎮痛外用剤
US20080255104A1 (en) * 2004-05-04 2008-10-16 Equitech Corporation Nsaid Compositions
BRPI0602825A2 (pt) * 2006-06-23 2012-04-24 Rhodia Br Ltda formulação de pó efervescente auto-refrigerante para bebidas e uso de formulação em pó efervescente
US20090258823A1 (en) * 2006-12-08 2009-10-15 George Caroline L S Composition and methods for the prevention and treatment of gastrointestinal infections
RU2660346C1 (ru) 2012-02-06 2018-07-05 Мериал, Инк. Паразитицидные пероральные ветеринарные композиции, включающие системно действующие активные агенты, способы и применение этих композиций и способов
NZ631100A (en) 2012-04-04 2016-06-24 Intervet Int Bv Soft chewable pharmaceutical products
WO2013169218A1 (en) * 2012-05-08 2013-11-14 Mahmut Bilgic Pharmaceutical compositions of s-etodolac

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260148A (en) * 1939-06-19 1941-10-21 Frank H Fleer Corp Chewing gum material
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4265847A (en) * 1978-03-30 1981-05-05 Kirby Pharmaceuticals Ltd Tabletting process
US4520203A (en) * 1983-08-16 1985-05-28 American Home Products Corporation Resolution of (±)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid using cinchonine
US4639368A (en) * 1984-08-23 1987-01-27 Farmacon Research Corporation Chewing gum containing a medicament and taste maskers
US4879108A (en) * 1985-12-20 1989-11-07 Warner-Lambert Company Confectionery delivery system for antipyretics
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE3669103D1 (de) * 1986-11-14 1990-04-05 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4835186A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US4835188A (en) * 1987-12-08 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US4942039A (en) * 1989-05-09 1990-07-17 Miles Inc. Effervescent analgesic antacid composition having reduced sodium content
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
EP0727994B1 (en) * 1992-03-13 2000-06-07 Sepracor, Inc. Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
AR003435A1 (es) 1998-08-05
CO4700456A1 (es) 1998-12-29
ZA964928B (en) 1997-12-10
NO962491L (no) 1996-12-16
EA199600029A2 (ru) 1996-12-30
KR970000228A (ko) 1997-01-21
MA23907A1 (fr) 1996-12-31
US5958445A (en) 1999-09-28
CZ170296A3 (en) 1997-04-16
TR199600499A2 (tr) 1996-12-21
HUP9601635A3 (en) 2000-06-28
HU9601635D0 (en) 1996-08-28
EE9600067A (et) 1996-12-16
CN1152434A (zh) 1997-06-25
IL118636A0 (en) 1996-10-16
PL314732A1 (en) 1996-12-23
SV1996000051A (es) 1997-02-17
EP0748628A2 (en) 1996-12-18
IL118636A (en) 2000-02-17
SK74396A3 (en) 1997-04-09
AU5588096A (en) 1997-01-02
PE10898A1 (es) 1998-03-20
IN182040B (pt) 1998-12-12
HUP9601635A2 (en) 1997-04-28
NZ286791A (en) 1998-01-26
EA199600029A3 (ru) 1997-03-31
CA2178686A1 (en) 1996-12-14
EA000047B1 (ru) 1998-04-30
NO962491D0 (no) 1996-06-12
AU711853B2 (en) 1999-10-21
SG46737A1 (en) 1998-02-20
EP0748628A3 (en) 1997-04-23
JPH093071A (ja) 1997-01-07

Similar Documents

Publication Publication Date Title
BR9602759A (pt) Composição farmacêutica oral organoleticamente aceitável
ATE284695T1 (de) Oral anzuwendende arzneizusammensetzung enthaltend 2-methyl-thienobenzodiazepin
BR9602758A (pt) Composição farmacêutica oral organoleticamente aceitável
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
FI963421A (fi) Oraalisia apuainekoostumuksia
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
BR9508844A (pt) Composição oral
NO20004345D0 (no) Farmasøytisk sammensetning
ID19097A (id) Komposisi-komposisi oral
DE69616545D1 (de) Zahnseide
BR9506536A (pt) Composição oral
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
DE59608344D1 (de) Interdental-Keil
BR9510467A (pt) Composições orais
BR9510307A (pt) Composições orais
FI973229A0 (fi) Uusi farmaseuttinen koostumus
LV11727A (lv) Farmaceitiska kompozicija
BR9606974A (pt) Composições orais
FI973280A0 (fi) Farmaseuttinen koostumus
ID19246A (id) Komposisi oral antikalkulus
ID19099A (id) Komposisi oral
BR9510459A (pt) Composições orais
DE29509846U1 (de) Interdentalzahnbürste
BR9605777A (pt) Composição farmacêutica

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]